Cargando…

Tissue-specific multi-omics analysis of atrial fibrillation

Genome-wide association studies (GWAS) for atrial fibrillation (AF) have uncovered numerous disease-associated variants. Their underlying molecular mechanisms, especially consequences for mRNA and protein expression remain largely elusive. Thus, refined multi-omics approaches are needed for decipher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assum, Ines, Krause, Julia, Scheinhardt, Markus O., Müller, Christian, Hammer, Elke, Börschel, Christin S., Völker, Uwe, Conradi, Lenard, Geelhoed, Bastiaan, Zeller, Tanja, Schnabel, Renate B., Heinig, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782899/ https://www.ncbi.nlm.nih.gov/pubmed/35064145 http://dx.doi.org/10.1038/s41467-022-27953-1

Ejemplares similares

Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
por: Geelhoed, Bastiaan, et al.
Publicado: (2020)

The Relationship Between Vitamin D and Postoperative Atrial Fibrillation: A Prospective Cohort Study
por: Ohlrogge, Amelie H., et al.
Publicado: (2022)

Risk prediction of atrial fibrillation in the community combining biomarkers and genetics
por: Börschel, Christin S, et al.
Publicado: (2021)

The imminent epidemic of atrial fibrillation and its concomitant diseases – Myocardial infarction and heart failure - A cause for concern
por: Börschel, Christin S., et al.
Publicado: (2019)

Periodontitis, dental plaque, and atrial fibrillation in the Hamburg City Health Study
por: Struppek, Julia, et al.
Publicado: (2021)

Inflammatory proteomics profiling for prediction of incident atrial fibrillation
por: Börschel, Christin S, et al.
Publicado: (2023)

An arrhythmogenic metabolite in atrial fibrillation
por: Krause, Julia, et al.
Publicado: (2023)

Mediterranean Diet and Atrial Fibrillation: Lessons Learned from the AFHRI Case–Control Study
por: Neumann, Felix Alexander, et al.
Publicado: (2022)

Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial Fibrillation
por: Camen, Stephan, et al.
Publicado: (2022)

Depression in Atrial Fibrillation in the General Population
por: Schnabel, Renate B., et al.
Publicado: (2013)

Multiple Biomarkers and Atrial Fibrillation in the General Population
por: Schnabel, Renate B., et al.
Publicado: (2014)

Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium
por: Morseth, Bente, et al.
Publicado: (2021)

Telomere length and incident atrial fibrillation – data of the PREVEND cohort
por: Siland, Joylene E., et al.
Publicado: (2017)

Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice
por: Schnabel, Renate B, et al.
Publicado: (2022)

Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation
por: Kany, Shinwan, et al.
Publicado: (2021)

Alcohol and atrial fibrillation: dose matters, not so much the type
por: Csengeri, Dora, et al.
Publicado: (2021)

Abnormal Calcium Handling in Atrial Fibrillation Is Linked to Changes in Cyclic AMP Dependent Signaling
por: Reinhardt, Franziska, et al.
Publicado: (2021)

Potential Impact of Oral Inflammations on Cardiac Functions and Atrial Fibrillation
por: Aarabi, Ghazal, et al.
Publicado: (2018)

Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial
por: Kany, Shinwan, et al.
Publicado: (2023)

Atrial fibrillation: villain or bystander in vascular brain injury
por: Freedman, Ben, et al.
Publicado: (2020)

Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death
por: Schrage, Benedikt, et al.
Publicado: (2020)

Gut microbiome and atrial fibrillation—results from a large population-based study
por: Palmu, Joonatan, et al.
Publicado: (2023)

Validating risk models versus age alone for atrial fibrillation in a young Dutch population cohort: should atrial fibrillation risk prediction be expanded to younger community members?
por: Himmelreich, Jelle C L, et al.
Publicado: (2022)

HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice
por: Scholz, Beatrix, et al.
Publicado: (2019)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Right Atrial Thrombosis in Antiphospholipid Syndrome with Secondary Immune Thrombocytopenia
por: Voigtlaender, Minna, et al.
Publicado: (2015)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Comparison of Cox Model Methods in A Low-dimensional Setting with Few Events
por: Ojeda, Francisco M., et al.
Publicado: (2016)

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death
por: Brady, Paul F., et al.
Publicado: (2022)

Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods
por: Toprak, Betül, et al.
Publicado: (2023)

Functional Characterization of Rare Variants in the SHOX2 Gene Identified in Sinus Node Dysfunction and Atrial Fibrillation
por: Hoffmann, Sandra, et al.
Publicado: (2019)

Screening for atrial fibrillation to prevent stroke: a meta-analysis
por: McIntyre, William F, et al.
Publicado: (2022)

Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?
por: Kany, Shinwan, et al.
Publicado: (2021)

Global Burden of Atrial Fibrillation and Flutter by National Income: Results From the Global Burden of Disease 2019 Database
por: Ohlrogge, Amelie H., et al.
Publicado: (2023)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Cross-Sectional Associations between Homoarginine, Intermediate Phenotypes, and Atrial Fibrillation in the Community—The Gutenberg Health Study
por: Niekamp, Christoph, et al.
Publicado: (2018)

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation
por: Siland, Joylene E., et al.
Publicado: (2020)

Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries
por: Mokgokong, Ruth, et al.
Publicado: (2022)

Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
por: Schnabel, Renate B., et al.
Publicado: (2018)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vh25m432243e2o5lsqqfus3vgd